Botanix Pharmaceuticals
Logotype for Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals (BOT) investor relations material

Botanix Pharmaceuticals H1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Botanix Pharmaceuticals Limited
H1 2026 earnings summary3 Mar, 2026

Executive summary

  • Sofdra® prescriptions reached 62,500 in the first 11 months, generating $93.5m gross and $21.2m net revenue.

  • Net sales revenue surged to $16.5 million for the half-year ended 31 December 2025, up from $0.35 million year-over-year, reflecting the ramp-up of Sofdra sales and marketing efforts.

  • Sofdra prescriptions shipped grew 171% to 45,769 in H1 FY26, with strong refill rates and adherence 2.5x the industry standard.

  • Sales force expanded to 50 representatives, completed in Q2 FY26, driving demand and compliance.

  • Firm commitments secured for A$45m capital raising to support API purchases, marketing, and working capital.

Financial highlights

  • 1H FY26 revenue was $16.5m, up 4671% year-over-year; net revenue for Sofdra® in 1H FY26 was $16.2m, up 219% sequentially.

  • Adjusted EBITDA for 1H FY26 was ($26.1)m; cash and cash equivalents stood at $31.6m.

  • Total expenses increased 55% year-over-year to $50.4m; loss before tax was ($33.2)m.

  • Share-based payments expense decreased to $6.3 million from $10.6 million year-over-year.

  • Net cash outflow from operating activities was $30.3 million, similar to the prior period.

Outlook and guidance

  • Selection of an alternate API supplier is expected to reduce COGS by 25–40%.

  • Management expects continued strong Sofdra sales growth, supported by expanded sales force and high physician intent to prescribe.

  • Platform is positioned for additional products, aiming to drive future growth and profitability.

  • Expansion of Sofdra licensing to other regions is planned.

  • Capital raising of up to $45 million post-period end to support operations and growth initiatives.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Botanix Pharmaceuticals earnings date

Logotype for Botanix Pharmaceuticals Limited
Q3 202622 Apr, 2026
Botanix Pharmaceuticals
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Botanix Pharmaceuticals earnings date

Logotype for Botanix Pharmaceuticals Limited
Q3 202622 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Botanix Pharmaceuticals Limited is a clinical-stage pharmaceutical company focused on developing treatments for dermatological and antimicrobial conditions. The company's pipeline leverages synthetic cannabidiol (CBD) to address skin diseases such as acne, rosacea, and atopic dermatitis, as well as infections caused by antimicrobial-resistant bacteria. Botanix’s products aim to offer innovative therapies that address unmet medical needs, especially in dermatology, by combining novel formulations with delivery systems that enhance drug efficacy. The company is headquartered in North Perth, Australia, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage